EQUAL ACCESS TO AFFORDABLE CARE A NOVARTIS COMMITMENT
LIVE

Serial Number

79175009

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 21, 2015

Add to watchlist:

No watchlists yet
View on USPTO

EQUAL ACCESS TO AFFORDABLE CARE A NOVARTIS COMMITMENT Trademark

Serial Number: 79175009 • Registration: 5047407

EQUAL ACCESS TO AFFORDABLE CARE A NOVARTIS COMMITMENT is a trademark filed by Novartis AG on July 21, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Novartis AG (16 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

July 21, 2015

Registration Date

September 27, 2016

Published for Opposition

April 5, 2016

Cancellation Date

July 21, 2025

Goods & Services

Surgical apparatus and instruments; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for facilitating inhalation of pharmaceutical preparations; medical apparatus for monitoring vital signs of patients; medical diagnostic apparatus for detecting cancer; medical apparatus and instruments for diagnostic radiopharmaceutical use; artificial limbs, eyes and teeth

Retail store services or wholesale store services featuring pharmaceutical products and medicines; business consultancy services in the field of pharmaceutical products and medicines; business management in the field of pharmaceutical products and medicines; business administration in the field of pharmaceutical products and medicines; office functions in the field of pharmaceutical products and medicines; advertising services in the field of pharmaceutical products and medicines; operation and management of a charity organization for others in the field of pharmaceutical products and medicines; retail store services featuring pharmaceutical products; provision of pricing information and advice for consumers in connection with the selection of pharmaceutical products for acquisition

Pharmaceutical products, namely, Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Medical services; provision of medical information relating to medical services

Medical training and teaching

Charitable fund collection services

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2026 DETH
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 14, 2023 INTR
CANCELLED SECTION 71
Apr 14, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 27, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 30, 2017 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 29, 2016 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 29, 2016 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2016 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 19, 2016 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
May 5, 2016 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 5, 2016 NPUB
PUBLISHED FOR OPPOSITION
Apr 5, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 16, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 2, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 2, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 2, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 2, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2016 REAP
REFUSAL PROCESSED BY IB
Dec 4, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2015 RFCS
REFUSAL PROCESSED BY MPU
Nov 13, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 10, 2015 RFCR
NON-FINAL ACTION WRITTEN
Nov 9, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 6, 2015 MAFR
ASSIGNED TO EXAMINER
Nov 2, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2015 REPR